Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
Explore more from The Transmitter
Susana Carmona on the neurobiology of pregnancy
In a Q&A about her new book, “A Mother’s Brain,” Carmona shares key moments in her career that led her to study the neuroscience of motherhood and discusses some of the major questions the field still needs to address.
Susana Carmona on the neurobiology of pregnancy
In a Q&A about her new book, “A Mother’s Brain,” Carmona shares key moments in her career that led her to study the neuroscience of motherhood and discusses some of the major questions the field still needs to address.
Aging biomarkers in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 October.
Aging biomarkers in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 October.
Beyond wiring diagrams: Inside a $19 million effort to expand access to connectome technology
Davi Bock’s lab took the millions of images that led to the complete connectome of a fruit fly brain. Now he wants to apply “this high-throughput flashlight across all areas of biology.”
Beyond wiring diagrams: Inside a $19 million effort to expand access to connectome technology
Davi Bock’s lab took the millions of images that led to the complete connectome of a fruit fly brain. Now he wants to apply “this high-throughput flashlight across all areas of biology.”